{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:56:39Z","timestamp":1785297399615,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["FinanceCode 001"],"award-info":[{"award-number":["FinanceCode 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["307186\/2017-2"],"award-info":[{"award-number":["307186\/2017-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303863\/2020-0"],"award-info":[{"award-number":["303863\/2020-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["014\/2017"],"award-info":[{"award-number":["014\/2017"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["014\/2017"],"award-info":[{"award-number":["014\/2017"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["014\/2017"],"award-info":[{"award-number":["014\/2017"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00210-022-02274-8","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:06:52Z","timestamp":1658228812000},"page":"1269-1282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model"],"prefix":"10.1007","volume":"395","author":[{"given":"Felipe Fagundes","family":"Le\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Farias","family":"Waltrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Waldiceu Aparecido","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joice Maria","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaina Menezes","family":"Zanoveli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"issue":"1","key":"2274_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12016-019-08754-9","volume":"58","author":"F Abdolmaleki","year":"2020","unstructured":"Abdolmaleki F, Kovanen PT, Mardani R, Gheibi-Hayat SM, Bo S, Sahebkar A (2020) Resolvins: emerging players in autoimmune and inflammatory diseases. Clin Rev Allergy Immunol 58(1):82\u201391. https:\/\/doi.org\/10.1007\/s12016-019-08754-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"2274_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-444-53480-4.00015-1","volume":"126","author":"U Alam","year":"2014","unstructured":"Alam U, Asghar O, Azmi S, Malik RA (2014) General aspects of diabetes mellitus. Handb Clin Neurol 126:211\u2013222. https:\/\/doi.org\/10.1016\/B978-0-444-53480-4.00015-1","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"2274_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/10520295.2013.825319","volume":"89","author":"M Ates","year":"2014","unstructured":"Ates M, Dayi A, Kiray M, Sisman AR, Agilkaya S, Aksu I, Baykara B, Buyuk E, Cetinkaya C, Cingoz S, Uysal N (2014) Anxiety- and depression-like behavior are correlated with leptin and leptin receptor expression in prefrontal cortex of streptozotocin-induced diabetic rats. Biotech Histochem: Off Publ Biol Stain Comm 89(3):161\u2013171. https:\/\/doi.org\/10.3109\/10520295.2013.825319","journal-title":"Biotech Histochem: Off Publ Biol Stain Comm"},{"issue":"2","key":"2274_CR4","first-page":"120","volume":"9","author":"SV B\u0103descu","year":"2016","unstructured":"B\u0103descu SV, T\u0103taru C, Kobylinska L, Georgescu EL, Zahiu DM, Z\u0103grean AM, Z\u0103grean L (2016) The association between diabetes mellitus and depression. J Med Life 9(2):120\u2013125","journal-title":"J Med Life"},{"issue":"6","key":"2274_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2337\/diacare.28.6.1371","volume":"28","author":"S Basu","year":"2005","unstructured":"Basu S, Larsson A, Vessby J, Vessby B, Berne C (2005) Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diabetes Care 28(6):1371\u20131375. https:\/\/doi.org\/10.2337\/diacare.28.6.1371","journal-title":"Diabetes Care"},{"issue":"4","key":"2274_CR6","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/ijms22041516","volume":"22","author":"S Bathina","year":"2021","unstructured":"Bathina S, Das UN (2021) Resolvin D1 Decreases severity of streptozotocin-induced type 1 diabetes mellitus by enhancing BDNF levels, reducing oxidative stress, and suppressing inflammation. Int J Mol Sci 22(4):1516. https:\/\/doi.org\/10.3390\/ijms22041516","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2274_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.arcmed.2020.05.002","volume":"51","author":"S Bathina","year":"2020","unstructured":"Bathina S, Gundala N, Rhenghachar P, Polavarapu S, Hari AD, Sadananda M, Das UM (2020) Resolvin D1 ameliorates nicotinamide-streptozotocin-induced type 2 diabetes mellitus by its anti-inflammatory action and modulating PI3K\/Akt\/mTOR pathway in the brain. Arch Med Res 51(6):492\u2013503. https:\/\/doi.org\/10.1016\/j.arcmed.2020.05.002","journal-title":"Arch Med Res"},{"issue":"1","key":"2274_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000135625","volume":"15","author":"J Beauquis","year":"2008","unstructured":"Beauquis J, Homo-Delarche F, Revsin Y, De Nicola AF, Saravia F (2008) Brain alterations in autoimmune and pharmacological models of diabetes mellitus: focus on hypothalamic-pituitary-adrenocortical axis disturbances. NeuroImmunoModulation 15(1):61\u201367. https:\/\/doi.org\/10.1159\/000135625","journal-title":"NeuroImmunoModulation"},{"issue":"1\u20132","key":"2274_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0166-4328(93)90100-5","volume":"58","author":"RJ Blanchard","year":"1993","unstructured":"Blanchard RJ, Yudko EB, Rodgers RJ, Blanchard DC (1993) Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behavi Brain Res 58(1\u20132):155\u2013165. https:\/\/doi.org\/10.1016\/0166-4328(93)90100-5","journal-title":"Behavi Brain Res"},{"key":"2274_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.psyneuen.2016.04.019","volume":"70","author":"B Buchberger","year":"2016","unstructured":"Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi JT, Siafarikas A (2016) Symptoms of depression and anxiety in youth with type 1 diabetes: a systematic review and meta-analysis. Psychoneuroendocrinology 70:70\u201384. https:\/\/doi.org\/10.1016\/j.psyneuen.2016.04.019","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"2274_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neubiorev.2005.04.017","volume":"29","author":"AP Carobrez","year":"2005","unstructured":"Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Ver 29(8):1193\u20131205. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.04.017","journal-title":"Neurosci Biobehav Ver"},{"key":"2274_CR12","doi-asserted-by":"publisher","first-page":"135020","DOI":"10.1016\/j.neulet.2020.135020","volume":"729","author":"YC Chaves","year":"2020","unstructured":"Chaves YC, Genaro K, Stern CA, de Oliveira GG, de Souza Crippa JA, da Cunha JM, Zanoveli JM (2020) Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. Neurosci Lett 729:135020. https:\/\/doi.org\/10.1016\/j.neulet.2020.135020","journal-title":"Neurosci Lett"},{"issue":"4","key":"2274_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11011-020-00667-3","volume":"36","author":"YC Chaves","year":"2021","unstructured":"Chaves YC, Genaro K, Crippa JA, da Cunha JM, Zanoveli JM (2021) Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action. Metab Brain Dis 36(4):639\u2013652. https:\/\/doi.org\/10.1007\/s11011-020-00667-3","journal-title":"Metab Brain Dis"},{"key":"2274_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","volume":"58","author":"N Chiang","year":"2017","unstructured":"Chiang N, Serhan CN (2017) Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 58:114\u2013129. https:\/\/doi.org\/10.1016\/j.mam.2017.03.005","journal-title":"Mol Aspects Med"},{"issue":"6","key":"2274_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/00008877-199312000-00003","volume":"4","author":"JC Cole","year":"1993","unstructured":"Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16\u20136028) in the murine elevated plus-maze. Behav Pharmacol 4(6):573\u2013580","journal-title":"Behav Pharmacol"},{"issue":"1","key":"2274_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","volume":"49","author":"AP Cruz","year":"1994","unstructured":"Cruz AP, Frei F, Graeff FG (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49(1):171\u2013176. https:\/\/doi.org\/10.1016\/0091-3057(94)90472-3","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"2274_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23(5):238\u2013245. https:\/\/doi.org\/10.1016\/s0165-6147(02)02017-5","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"2274_CR18","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1007\/s12035-015-9617-0","volume":"53","author":"IC da Silva Dias","year":"2016","unstructured":"da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC, Rizzo de Souza LE, Zanata SM, Brand\u00e3o ML, Cunha TM, Ferraz AC, Cunha JM, Zanoveli JM (2016) Indoleamine-2,3-dioxygenase\/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Mol Neurob 53(10):6997\u20137009. https:\/\/doi.org\/10.1007\/s12035-015-9617-0","journal-title":"Mol Neurob"},{"issue":"3","key":"2274_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1538\/expanim.63.277","volume":"63","author":"JP Dami\u00e1n","year":"2014","unstructured":"Dami\u00e1n JP, Acosta V, Da Cu\u00f1a M, Ram\u00edrez I, Oddone N, Zambrana A, Bervejillo V, Benech JC (2014) Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim 63(3):277\u2013287. https:\/\/doi.org\/10.1538\/expanim.63.277","journal-title":"Exp Anim"},{"issue":"3","key":"2274_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.plefa.2012.11.009","volume":"88","author":"UN Das","year":"2013","unstructured":"Das UN (2013) Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids 88(3):201\u2013210. https:\/\/doi.org\/10.1016\/j.plefa.2012.11.009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2274_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2013.10.011","volume":"258","author":"H de Morais","year":"2014","unstructured":"de Morais H, de Souza CP, da Silva LM, Ferreira DM, Werner MF, Andreatini R, da Cunha JM, Zanoveli JM (2014) Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behav Brain Res 258:52\u201364. https:\/\/doi.org\/10.1016\/j.bbr.2013.10.011","journal-title":"Behav Brain Res"},{"issue":"3","key":"2274_CR22","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s12035-016-9803-8","volume":"54","author":"AM Delattre","year":"2017","unstructured":"Delattre AM, Carabelli B, Mori MA, Kempe PG, Rizzo de Souza LE, Zanata SM, Machado RB, Suchecki D, Andrade da Costa B, Lima M, Ferraz AC (2017) Maternal omega-3 supplement improves dopaminergic system in pre- and postnatal inflammation-induced neurotoxicity in Parkinson\u2019s disease model. Mol Neurobiol 54(3):2090\u20132106. https:\/\/doi.org\/10.1007\/s12035-016-9803-8","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2274_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121(1):66\u201372. https:\/\/doi.org\/10.1007\/BF02245592","journal-title":"Psychopharmacology"},{"issue":"7","key":"2274_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ijnp\/pyx023","volume":"20","author":"S Deyama","year":"2017","unstructured":"Deyama S, Ishikawa Y, Yoshikawa K, Shimoda K, Ide S, Satoh M, Minami M (2017) Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway. Int J Neuropsychopharmacol 20(7):575\u2013584. https:\/\/doi.org\/10.1093\/ijnp\/pyx023","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"2274_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jphs.2021.05.002","volume":"147","author":"S Deyama","year":"2021","unstructured":"Deyama S, Minami M, Kaneda K (2021) Resolvins as potential candidates for the treatment of major depressive disorder. J Pharmacol Sci 147(1):33\u201339. https:\/\/doi.org\/10.1016\/j.jphs.2021.05.002","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"2274_CR26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1476-5381.2010.01145.x","volume":"162","author":"S Dhayal","year":"2011","unstructured":"Dhayal S, Morgan NG (2011) Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cells. Br J Pharmacol 162(6):1340\u20131350. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01145.x","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2274_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12944-018-0938-7","volume":"18","author":"GT D\u00edaz-Gerevini","year":"2019","unstructured":"D\u00edaz-Gerevini GT, Da\u00edn A, Pasqualini ME, L\u00f3pez CB, Eynard AR, Repossi G (2019) Diabetic encephalopathy: beneficial effects of supplementation with fatty acids \u03c93 and nordihydroguaiaretic acid in a spontaneous diabetes rat model. Lipids Health Dis 18(1):43. https:\/\/doi.org\/10.1186\/s12944-018-0938-7","journal-title":"Lipids Health Dis"},{"issue":"11","key":"2274_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/bph.14647","volume":"176","author":"V Fattori","year":"2019","unstructured":"Fattori V, Pinho-Ribeiro FA, Staurengo-Ferrari L, Borghi SM, Rossaneis AC, Casagrande R, Verri WA Jr (2019) The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect. Br J Pharmacol 176(11):1728\u20131744. https:\/\/doi.org\/10.1111\/bph.14647","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2274_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1172\/JCI131609","volume":"130","author":"MB Flak","year":"2020","unstructured":"Flak MB, Koenis DS, Sobrino A, Smith J, Pistorius K, Palmas F, Dalli J (2020) GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections. J Clin Invest 130(1):359\u2013373. https:\/\/doi.org\/10.1172\/JCI131609","journal-title":"J Clin Invest"},{"issue":"3","key":"2274_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11011-015-9770-1","volume":"31","author":"E Gambeta","year":"2016","unstructured":"Gambeta E, de Souza CP, de Morais H, Zanoveli JM (2016) Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin. Metab Brain Dis 31(3):563\u2013571. https:\/\/doi.org\/10.1007\/s11011-015-9770-1","journal-title":"Metab Brain Dis"},{"key":"2274_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fpsyt.2020.00122","volume":"11","author":"J Giacobbe","year":"2020","unstructured":"Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A (2020) The anti-inflammatory role of omega-3 polyunsaturated fatty acids metabolites in pre-clinical models of psychiatric, neurodegenerative, and neurological disorders. Front Psychiatry 11:122. https:\/\/doi.org\/10.3389\/fpsyt.2020.00122","journal-title":"Front Psychiatry"},{"issue":"15","key":"2274_CR32","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1073\/pnas.1617290114","volume":"114","author":"T Gobbetti","year":"2017","unstructured":"Gobbetti T, Dalli J, Colas RA, Federici Canova D, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C, Hansen TV, Serhan CN, Perretti M (2017) Protectin D1n\u20133 DPA and resolvin D5n\u20133 DPA are effectors of intestinal protection. Proc Natl Acad Sci U S A 114(15):3963\u20133968. https:\/\/doi.org\/10.1073\/pnas.1617290114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2274_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/s0091-3057(96)00402-9","volume":"57","author":"G Griebel","year":"1997","unstructured":"Griebel G, Rodgers RJ, Perrault G, Sanger DJ (1997) Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol Biochem Behav 57(4):817\u2013827. https:\/\/doi.org\/10.1016\/s0091-3057(96)00402-9","journal-title":"Pharmacol Biochem Behav"},{"key":"2274_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.nut.2016.10.004","volume":"35","author":"N Gundala","year":"2017","unstructured":"Gundala N, Naidu V, Das UN (2017) Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo. Nutrition 35:61\u201380. https:\/\/doi.org\/10.1016\/j.nut.2016.10.004","journal-title":"Nutrition"},{"issue":"4","key":"2274_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/iep.12284","volume":"99","author":"S Hammadi","year":"2018","unstructured":"Hammadi S, Chan O, Abdellali M, Medjerab M, Agoun H, Bellahreche Z, Khalkhal A, Dahmani Y (2018) Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetic gerbils (Gerbillus gerbillus). Int J Exp Pathol 99(4):172\u2013179. https:\/\/doi.org\/10.1111\/iep.12284","journal-title":"Int J Exp Pathol"},{"key":"2274_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbi.2016.12.025","volume":"61","author":"C Herder","year":"2017","unstructured":"Herder C, F\u00fcrstos JF, Nowotny B, Begun A, Strassburger K, M\u00fcssig K, Szendroedi J, Icks A, Roden M, GDS Group (2017) Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes. Brain Behav Immun 61:137\u2013145. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.025","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2274_CR37","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.neubiorev.2013.03.010","volume":"37","author":"N Ho","year":"2013","unstructured":"Ho N, Sommers MS, Lucki I (2013) Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobeha Rev 37(8):1346\u20131362. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.03.010","journal-title":"Neurosci Biobeha Rev"},{"issue":"12","key":"2274_CR38","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2337\/dc11-2329","volume":"35","author":"KK Hood","year":"2012","unstructured":"Hood KK, Lawrence JM, Anderson A, Bell R, Dabelea D, Daniels S, Rodriguez B, Dolan LM, SEARCH for Diabetes in Youth Study Group (2012) Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care 35(12):2443\u20132446. https:\/\/doi.org\/10.2337\/dc11-2329","journal-title":"Diabetes Care"},{"key":"2274_CR39","unstructured":"International Diabetes Federation (IDF) (2019) IDF Diabetes Atlas. 9th edition. https:\/\/www.diabetesatlas.org\/upload\/resources\/material\/20200302_133351_IDFATLAS9e-final-web.pdf"},{"key":"2274_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbr.2017.06.010","volume":"332","author":"Y Ishikawa","year":"2017","unstructured":"Ishikawa Y, Deyama S, Shimoda K, Yoshikawa K, Ide S, Satoh M, Minami M (2017) Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model. Behav Brain Res 332:233\u2013236. https:\/\/doi.org\/10.1016\/j.bbr.2017.06.010","journal-title":"Behav Brain Res"},{"issue":"9","key":"2274_CR41","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1007\/s12035-020-01980-9","volume":"57","author":"EY Kim","year":"2020","unstructured":"Kim EY, Choi JE, Kim M, Hong J, Park Y (2020) N-3 PUFA have antidepressant-like effects via improvement of the HPA-axis and neurotransmission in rats exposed to combined stress. Mol Neurobiol 57(9):3860\u20133874. https:\/\/doi.org\/10.1007\/s12035-020-01980-9","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2274_CR42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.0708092105","volume":"105","author":"JW Koo","year":"2008","unstructured":"Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 105(2):751\u2013756. https:\/\/doi.org\/10.1073\/pnas.0708092105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2274_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2009.03.068","volume":"456","author":"JW Koo","year":"2009","unstructured":"Koo JW, Duman RS (2009) Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 456(1):39\u201343. https:\/\/doi.org\/10.1016\/j.neulet.2009.03.068","journal-title":"Neurosci Lett"},{"issue":"6","key":"2274_CR44","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1073\/pnas.0910658107","volume":"107","author":"JW Koo","year":"2010","unstructured":"Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010) Nuclear factor-kappa B is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A 107(6):2669\u20132674. https:\/\/doi.org\/10.1073\/pnas.0910658107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2274_CR45","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1073\/pnas.0907342107","volume":"107","author":"S Krishnamoorthy","year":"2010","unstructured":"Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN (2010) Resolvin D1 binds human phagocytes with evidence for pro resolving receptors. Proc Natl Acad Sci U S A 107(4):1660\u20131665. https:\/\/doi.org\/10.1073\/pnas.0907342107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2274_CR46","doi-asserted-by":"publisher","unstructured":"Lin LW, Tsai FS, Yang WT, Lai SC, Shih CC, Lee SC, Wu CR (2018) Differential change in cortical and hippocampal monoamines, and behavioral patterns in streptozotocin-induced type 1 diabetic rats.\u00a0Iran J Basic Med Sci 21(10):1026\u20131034. https:\/\/doi.org\/10.22038\/IJBMS.2018.29810.7197","DOI":"10.22038\/IJBMS.2018.29810.7197"},{"key":"2274_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fphar.2019.00745","volume":"10","author":"X Luo","year":"2019","unstructured":"Luo X, Gu Y, Tao X, Serhan CN, Ji RR (2019) Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy. Front Pharmacol 10:745. https:\/\/doi.org\/10.3389\/fphar.2019.00745","journal-title":"Front Pharmacol"},{"key":"2274_CR48","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1155\/2014\/102158","volume":"2014","author":"M Muriach","year":"2014","unstructured":"Muriach M, Flores-Bellver M, Romero FJ, Barcia JM (2014) Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Long 2014:102158. https:\/\/doi.org\/10.1155\/2014\/102158","journal-title":"Oxid Med Cell Long"},{"issue":"8","key":"2274_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jdiacomp.2019.04.013","volume":"33","author":"G Nefs","year":"2019","unstructured":"Nefs G, Hendrieckx C, Reddy P, Browne JL, Bot M, Dixon J, Kyrios M, Speight J, Pouwer F (2019) Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: results from the International Diabetes MILES Study. J Diabetes Complications 33(8):523\u2013529. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.04.013","journal-title":"J Diabetes Complications"},{"issue":"4","key":"2274_CR50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/pedi.13174","volume":"22","author":"LA Nguyen","year":"2021","unstructured":"Nguyen LA, Pouwer F, Winterdijk P, Hartman E, Nuboer R, Sas T, de Kruijff I, Bakker-Van Waarde W, Aanstoot HJ, Nefs G (2021) Prevalence and course of mood and anxiety disorders, and correlates of symptom severity in adolescents with type 1 diabetes: results from diabetes LEAP. Pediatr Diabetes 22(4):638\u2013648. https:\/\/doi.org\/10.1111\/pedi.13174","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 1","key":"2274_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11789-017-0084-1","volume":"12","author":"E Ors\u00f3","year":"2017","unstructured":"Ors\u00f3 E, Schmitz G (2017) Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies. Clin Res Cardiol Suppl 12(Suppl 1):31\u201337. https:\/\/doi.org\/10.1007\/s11789-017-0084-1","journal-title":"Clin Res Cardiol Suppl"},{"issue":"10","key":"2274_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4149\/bll_2012_130","volume":"113","author":"N Pamidi","year":"2012","unstructured":"Pamidi N, Satheesha Nayak BN (2012) Effect of streptozotocin induced diabetes on rat hippocampus. Bratisl Lek Listy 113(10):583\u2013588. https:\/\/doi.org\/10.4149\/bll_2012_130","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"2274_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1021\/acsptsci.9b00075","volume":"3","author":"J Park","year":"2020","unstructured":"Park J, Langmead CJ, Riddy DM (2020) New advances in targeting the resolution of inflammation: implications for specialized pro-resolving mediator GPCR drug discovery. ACS Pharmacol Transl Sci 3(1):88\u2013106. https:\/\/doi.org\/10.1021\/acsptsci.9b00075","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"3","key":"2274_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14(3):149\u2013167. https:\/\/doi.org\/10.1016\/0165-0270(85)90031-7","journal-title":"J Neurosci Methods"},{"issue":"5","key":"2274_CR55","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11011-018-0264-9","volume":"33","author":"MM Pereira","year":"2018","unstructured":"Pereira MM, de Morais H, dos Santos SE, Corso CR, Adami ER, Carlos RM, Acco A, Zanoveli JM (2018) The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes. Metab Brain Dis 33(5):1573\u20131584. https:\/\/doi.org\/10.1007\/s11011-018-0264-9","journal-title":"Metab Brain Dis"},{"issue":"9","key":"2274_CR56","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/mds.28124","volume":"35","author":"I P\u00e9rez-Taboada","year":"2020","unstructured":"P\u00e9rez-Taboada I, Alberquilla S, Mart\u00edn ED, Anand R, Vietti-Michelina S, Tebeka NN, Cantley J, Cragg SJ, Moratalla R, Vallejo M (2020) Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice. Mov Disord 35(9):1636\u20131648. https:\/\/doi.org\/10.1002\/mds.28124","journal-title":"Mov Disord"},{"issue":"4","key":"2274_CR57","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47(4):379\u2013391. https:\/\/doi.org\/10.1016\/0014-2999(78)90118-8","journal-title":"Eur J Pharmacol"},{"key":"2274_CR58","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"5","author":"S Pugazhenthi","year":"1863","unstructured":"Pugazhenthi S, Qin L (1863) Reddy PH (2017) Common neurodegenerative pathways in obesity, diabetes, and Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 5:1037\u20131045. https:\/\/doi.org\/10.1016\/j.bbadis.2016.04.017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Pt B","key":"2274_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2015.10.058","volume":"298","author":"DD Redivo","year":"2016","unstructured":"Redivo DD, Schreiber AK, Adami ER, Ribeiro DE, Joca SR, Zanoveli JM, Cunha JM (2016) Effect of omega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes. Behav Brain Res 298(Pt B):57\u201364. https:\/\/doi.org\/10.1016\/j.bbr.2015.10.058","journal-title":"Behav Brain Res"},{"issue":"2","key":"2274_CR60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0031-9384(93)90222-2","volume":"53","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Cole JC (1993) Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors. Physiol Behav 53(2):383\u2013388. https:\/\/doi.org\/10.1016\/0031-9384(93)90222-2","journal-title":"Physiol Behav"},{"issue":"4","key":"2274_CR61","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0031-9384(93)90084-s","volume":"54","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Cole JC (1993) Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol Behav 54(4):729\u2013736. https:\/\/doi.org\/10.1016\/0031-9384(93)90084-s","journal-title":"Physiol Behav"},{"issue":"2","key":"2274_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbr.2004.03.010","volume":"154","author":"V Roy","year":"2004","unstructured":"Roy V, Chapillon P (2004) Further evidence that risk assessment and object exploration behaviours are useful to evaluate emotional reactivity in rodents. Behav Brain Res 154(2):439\u2013448. https:\/\/doi.org\/10.1016\/j.bbr.2004.03.010","journal-title":"Behav Brain Res"},{"issue":"7","key":"2274_CR63","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/JCI97943","volume":"128","author":"CN Serhan","year":"2018","unstructured":"Serhan CN, Levy BD (2018) Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 128(7):2657\u20132669. https:\/\/doi.org\/10.1172\/JCI97943","journal-title":"J Clin Invest"},{"issue":"5","key":"2274_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349\u2013361. https:\/\/doi.org\/10.1038\/nri2294","journal-title":"Nat Rev Immunol"},{"key":"2274_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbr.2017.03.008","volume":"326","author":"IP Siba","year":"2017","unstructured":"Siba IP, Bortolanza M, Fraz\u00e3o Vital M, Andreatini R, da Cunha JM, Del Bel EA, Zanoveli JM (2017) Fish oil prevents rodent anxious states comorbid with diabetes: a putative involvement of nitric oxide modulation. Behav Brain Res 326:173\u2013186. https:\/\/doi.org\/10.1016\/j.bbr.2017.03.008","journal-title":"Behav Brain Res"},{"issue":"2","key":"2274_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0091-3057(99)00193-8","volume":"65","author":"RC Silva","year":"2000","unstructured":"Silva RC, Brand\u00e3o ML (2000) Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 65(2):209\u2013216. https:\/\/doi.org\/10.1016\/s0091-3057(99)00193-8","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"2274_CR67","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery DA, Cryan JF (2012) Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 7(6):1009\u20131014. https:\/\/doi.org\/10.1038\/nprot.2012.044","journal-title":"Nat Protoc"},{"issue":"2","key":"2274_CR68","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/ijms21020540","volume":"21","author":"G Soto","year":"2020","unstructured":"Soto G, Rodr\u00edguez MJ, Fuentealba R, Treuer AV, Castillo I, Gonz\u00e1lez DR, Z\u00fa\u00f1iga-Hern\u00e1ndez J (2020) Maresin 1, a proresolving lipid mediator, ameliorates liver ischemia-reperfusion injury and stimulates hepatocyte proliferation in Sprague-Dawley rats. Int J Mol Sci 21(2):540. https:\/\/doi.org\/10.3390\/ijms21020540","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2274_CR69","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.biopsych.2014.01.008","volume":"76","author":"KP Su","year":"2014","unstructured":"Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, Chang HC, Pariante CM (2014) Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry 76(7):559\u2013566. https:\/\/doi.org\/10.1016\/j.biopsych.2014.01.008","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2274_CR70","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0899-9007(02)00855-9","volume":"19","author":"Y Suresh","year":"2003","unstructured":"Suresh Y, Das UN (2003) Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus Effect of omega-3 fatty acids. Nutrition 19(3):213\u2013228. https:\/\/doi.org\/10.1016\/s0899-9007(02)00855-9","journal-title":"Nutrition"},{"key":"2274_CR71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2012.03.021","volume":"1453","author":"R Vargas","year":"2012","unstructured":"Vargas R, Rinc\u00f3n J, Pedrea\u00f1ez A, Viera N, Hern\u00e1ndez-Fonseca JP, Pe\u00f1a C, Mosquera J (2012) Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats. Brain Res 1453:64\u201376. https:\/\/doi.org\/10.1016\/j.brainres.2012.03.021","journal-title":"Brain Res"},{"issue":"1","key":"2274_CR72","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuropharm.2011.06.017","volume":"62","author":"A Vines","year":"2012","unstructured":"Vines A, Delattre AM, Lima MM, Rodrigues LS, Suchecki D, Machado RB, Tufik S, Pereira SI, Zanata SM, Ferraz AC (2012) The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 62(1):184\u2013191. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.017","journal-title":"Neuropharmacology"},{"issue":"4","key":"2274_CR73","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/nu13041070","volume":"13","author":"M Wolters","year":"2021","unstructured":"Wolters M, von der Haar A, Baalmann AK, Wellbrock M, Heise TL, Rach S (2021) Effects of n-3 polyunsaturated fatty acid supplementation in the prevention and treatment of depressive disorders - a systematic review and meta-analysis. Nutrients 13(4):1070. https:\/\/doi.org\/10.3390\/nu13041070","journal-title":"Nutrients"},{"issue":"4","key":"2274_CR74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/nu8040243","volume":"8","author":"YQ Wu","year":"2016","unstructured":"Wu YQ, Dang RL, Tang MM, Cai HL, Li HD, Liao DH, He X, Cao LJ, Xue Y, Jiang P (2016) Long chain omega-3 polyunsaturated fatty acid supplementation alleviates doxorubicin-induced depressive-like behaviors and neurotoxicity in rats: involvement of oxidative stress and neuroinflammation. Nutrients 8(4):243. https:\/\/doi.org\/10.3390\/nu8040243","journal-title":"Nutrients"},{"key":"2274_CR75","doi-asserted-by":"publisher","first-page":"729134","DOI":"10.3389\/fphys.2021.729134","volume":"12","author":"TH Zaninelli","year":"2021","unstructured":"Zaninelli TH, Fattori V, Verri WA Jr (2021) Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators\u2019 contribution to arthritis physiopathology and future perspectives. Front Physiol 12:729134. https:\/\/doi.org\/10.3389\/fphys.2021.729134","journal-title":"Front Physiol"},{"issue":"3","key":"2274_CR76","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1573399811666150515125349","volume":"12","author":"JM Zanoveli","year":"2016","unstructured":"Zanoveli JM, de Morais H, Dias IC, Schreiber AK, Souza CP, Cunha JM (2016) Depression associated with diabetes: from pathophysiology to treatment. Curr Diabetes Rev 12(3):165\u2013178. https:\/\/doi.org\/10.2174\/1573399811666150515125349","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"2274_CR77","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ar.2334","volume":"299","author":"F Zhao","year":"2016","unstructured":"Zhao F, Li J, Mo L, Tan M, Zhang T, Tang Y, Zhao Y (2016) Changes in neurons and synapses in hippocampus of streptozotocin-induced type 1 diabetes rats: a stereological investigation. Anat Rec (hoboken) 299(9):1174\u20131183. https:\/\/doi.org\/10.1002\/ar.2334","journal-title":"Anat Rec (hoboken)"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02274-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T02:05:08Z","timestamp":1663034708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02274-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"7 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}